For some cancer cells, including AML cells [123] and thyroid cancer cells [124], Gwl depletion was specifically affecting tumoral but not normal cells, pointing to Gwl as a novel therapeutic target. The gene discussed is MASTL; the disease is acute myeloid leukemia.